Literature DB >> 30159953

Establishing intra- and inter-vendor reproducibility of T1 relaxation time measurements with 3T MRI.

Yoojin Lee1, Martina F Callaghan2, Julio Acosta-Cabronero2, Antoine Lutti3, Zoltan Nagy1.   

Abstract

PURPOSE: Parametric imaging methods (e.g., T1 relaxation time mapping) have been shown to be more reproducible across time and vendors than weighted (e.g., T1 -weighted) images. The purpose of this work was to more extensively evaluate the validity of this assertion.
METHODS: Seven volunteers underwent twice-repeated acquisitions of variable flip-angle T1 mapping, including B1 + calibration, on a 3T Philips Achieva and 3T Siemens Trio scanner. Intra-scanner and inter-vendor T1 variability were calculated. To determine T1 reproducibility levels in longitudinal settings, or after changing hardware or software, four additional data sets were acquired from two of the participants; one participant was scanned on a different 3T Siemens Trio scanner and another on the same 3T Philips Achieva scanner but after a software upgrade.
RESULTS: Intra-scanner variability of voxel-wise T1 values was consistent between the two vendors, averaging 0.7/0.7/1.3/1.4% in white matter/cortical gray matter/subcortical gray matter/cerebellum, respectively. We observed, however, a systematic bias between the two vendors of https://doi.org/10.0/7.8/8.6/10.0%, respectively. The T1 bias across two scanners of the same model was greater than intra-scanner variability, although still only at 1.4/1.0/1.9/2.3%, respectively. A greater bias was identified for data sets acquired before/after software upgrade in white matter/cortical gray matter (3.6/2.7%) whereas variability in subcortical gray matter/cerebellum was comparable (1.7/1.9%).
CONCLUSION: We established intra- and inter-vendor reproducibility levels for a widely used T1 mapping protocol. We anticipate that these results will guide the design of multi-center studies, particularly those encompassing multiple vendors. Furthermore, this baseline level of reproducibility should be established or surpassed during the piloting phase of such studies.
© 2018 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  3T; T1 relaxation; bias; multi-vendor; parametric imaging; reproducibility

Mesh:

Year:  2018        PMID: 30159953     DOI: 10.1002/mrm.27421

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  11 in total

Review 1.  Challenges in ensuring the generalizability of image quantitation methods for MRI.

Authors:  Kathryn E Keenan; Jana G Delfino; Kalina V Jordanova; Megan E Poorman; Prathyush Chirra; Akshay S Chaudhari; Bettina Baessler; Jessica Winfield; Satish E Viswanath; Nandita M deSouza
Journal:  Med Phys       Date:  2021-09-29       Impact factor: 4.506

2.  Reliability of quantitative multiparameter maps is high for magnetization transfer and proton density but attenuated for R1 and R2 * in healthy young adults.

Authors:  Elisabeth Wenger; Sarah E Polk; Maike M Kleemeyer; Nikolaus Weiskopf; Nils C Bodammer; Ulman Lindenberger; Andreas M Brandmaier
Journal:  Hum Brain Mapp       Date:  2022-04-09       Impact factor: 5.399

Review 3.  Repetitive MRI of organs at risk in head and neck cancer patients undergoing radiotherapy.

Authors:  Sonja Stieb; Baher Elgohari; Clifton David Fuller
Journal:  Clin Transl Radiat Oncol       Date:  2019-04-26

4.  Robust 3D Bloch-Siegert based B 1 + mapping using multi-echo general linear modeling.

Authors:  Nadège Corbin; Julio Acosta-Cabronero; Shaihan J Malik; Martina F Callaghan
Journal:  Magn Reson Med       Date:  2019-07-18       Impact factor: 4.668

5.  Controlled saturation magnetization transfer for reproducible multivendor variable flip angle T1 and T2 mapping.

Authors:  Rui Pedro A G Teixeira; Radhouene Neji; Tobias C Wood; Ana A Baburamani; Shaihan J Malik; Joseph V Hajnal
Journal:  Magn Reson Med       Date:  2019-12-17       Impact factor: 3.737

6.  Multi-site, multi-platform comparison of MRI T1 measurement using the system phantom.

Authors:  Kathryn E Keenan; Zydrunas Gimbutas; Andrew Dienstfrey; Karl F Stupic; Michael A Boss; Stephen E Russek; Thomas L Chenevert; P V Prasad; Junyu Guo; Wilburn E Reddick; Kim M Cecil; Amita Shukla-Dave; David Aramburu Nunez; Amaresh Shridhar Konar; Michael Z Liu; Sachin R Jambawalikar; Lawrence H Schwartz; Jie Zheng; Peng Hu; Edward F Jackson
Journal:  PLoS One       Date:  2021-06-30       Impact factor: 3.240

7.  hMRI - A toolbox for quantitative MRI in neuroscience and clinical research.

Authors:  Karsten Tabelow; Evelyne Balteau; John Ashburner; Martina F Callaghan; Bogdan Draganski; Gunther Helms; Ferath Kherif; Tobias Leutritz; Antoine Lutti; Christophe Phillips; Enrico Reimer; Lars Ruthotto; Maryam Seif; Nikolaus Weiskopf; Gabriel Ziegler; Siawoosh Mohammadi
Journal:  Neuroimage       Date:  2019-01-21       Impact factor: 6.556

8.  Multiparameter mapping of relaxation (R1, R2*), proton density and magnetization transfer saturation at 3 T: A multicenter dual-vendor reproducibility and repeatability study.

Authors:  Tobias Leutritz; Maryam Seif; Gunther Helms; Rebecca S Samson; Armin Curt; Patrick Freund; Nikolaus Weiskopf
Journal:  Hum Brain Mapp       Date:  2020-07-08       Impact factor: 5.399

Review 9.  Variability and Standardization of Quantitative Imaging: Monoparametric to Multiparametric Quantification, Radiomics, and Artificial Intelligence.

Authors:  Akifumi Hagiwara; Shohei Fujita; Yoshiharu Ohno; Shigeki Aoki
Journal:  Invest Radiol       Date:  2020-09       Impact factor: 10.065

10.  Consensus-based technical recommendations for clinical translation of renal T1 and T2 mapping MRI.

Authors:  Ilona A Dekkers; Anneloes de Boer; Kaniska Sharma; Eleanor F Cox; Hildo J Lamb; David L Buckley; Octavia Bane; David M Morris; Pottumarthi V Prasad; Scott I K Semple; Keith A Gillis; Paul Hockings; Charlotte Buchanan; Marcos Wolf; Christoffer Laustsen; Tim Leiner; Bryan Haddock; Johannes M Hoogduin; Pim Pullens; Steven Sourbron; Susan Francis
Journal:  MAGMA       Date:  2019-11-22       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.